+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cough, Cold and Allergy (Hay Fever) Remedies in Ukraine

  • PDF Icon

    Report

  • 26 Pages
  • September 2021
  • Region: Ukraine
  • Euromonitor International
  • ID: 349028
Cough, cold and allergy (hay fever) remedies are expected to register a value decline in 2021, with social distancing measures imposed to curb the spread of COVID-19, also curbing the spread of the common cold and flu. As a result, there is expected to continue to be less demand for cough and cold medicines. All the same, when buying cough, cold and allergy (hay fever) remedies, consumers are prioritising quality and cheaper brands such as Mukaltin are expected to lose value share.

The publisher's Cough, Cold and Allergy (Hay Fever) Remedies in Ukraine report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage:


Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage:


Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?


  • Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

KEY DATA FINDINGS
2021 DEVELOPMENTS
  • COVID-19 restrictions lower prevalence of common cold
  • Fragmentation continues with local companies leading through lower prices
  • Self-medication dampens value sales

PROSPECTS AND OPPORTUNITIES
  • COVID-19 has lasting impact
  • Oral decongestants and combination products drive value sales over forecast period
  • Quality over price key factor over forecast period

CATEGORY DATA
  • Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
  • Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
  • Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021
  • Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021
  • Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026
  • Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026

CONSUMER HEALTH IN UKRAINE
EXECUTIVE SUMMARY
  • Consumer health in 2021: The big picture
  • 2021 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?

MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
  • Table 8 Life Expectancy at Birth 2016-2021

MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2016-2021
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2016-2021
  • Table 11 NBO Company Shares of Consumer Health: % Value 2017-2021
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2018-2021
  • Table 13 Distribution of Consumer Health by Format: % Value 2016-2021
  • Table 14 Distribution of Consumer Health by Format and Category: % Value 2021
  • Table 15 Forecast Sales of Consumer Health by Category: Value 2021-2026
  • Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026

APPENDIX
OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches

DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources